Effect of vitamin E on protein bound carbhohydrate complexes in radiation treated oral squamous cell carcinoma patients

Indian Journal of Clinical Biochemistry

Volumn 23, Issue 1, 2008, Pages 92-94

  Chitra, S ^a,b   Shyamala Devi, C S ^a  

^a UNIVERSITY OF MADRAS   (India)

^b SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Glycoproteins; Oral squamous cell carcinoma; Radiotherapy; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; FUCOSE; GLYCOCONJUGATE; GLYCOPROTEIN; HEXOSAMINE; HEXOSE; SIALIC ACID;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MALE; MOUTH CARCINOMA; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; VITAMIN SUPPLEMENTATION;

EID: 45749117912     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12291-008-0022-6     Document Type: Article

References (27)

1. Baxi BR, Patel PS, Adhvaryu SG, Dayal PK. Usefulness of serum glycoconjugates in precancerous and cancerous diseases of the oral cavity. Cancer 1991; 67: 735 - 40.
2. Manoharan S, Padmanabhan M, Kolanjiappan K, Ramachandran CR, Suresh K. Analysis of glycoconjugates in patients with oral squamous cell carcinoma. Clinica Chemica Acta 2004; 339: 91 - 6
3. Ravas GN, Parekh LJ, Patel DD, Jha FP, Sainger RN, Patel PS. Clinical usefulness of alterations in sialic acid, sialyltransferase and sialoproteins in breast cancer. Ind J Clin Biochem 2004; 19: 60 - 71.
4. Patel PS, Adhvaryu SG, Balar DB, Parikh B.J, Shah PM. Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumor markers in human leukemias. Anti Cancer Res 1994; 14: 747 - 51.
5. Turner GA, Skillen AW, Buaman P. Relationship between raised concentration of fucose, sialic acid and acute phase proteins in serum from patients with cancer choosing suitable serum glycoprotein markets. J Clin Pathol.1985; 38: 588 - 93.
6. Tewarson SL, Mittal VP, Singh M Gupta SP. Serum sialic acid - an important cancer marker. Ind J Cancer 1993; 30: 125 - 31.
7. Kokogly E, Sonmez H Uslu I. Sialic acid levels in various types of cancer. Cancer Biochem Biophys 1992; 13: 57 - 64.
8. Kumar P. Tumor hypoxia and anemia. Impact on the efficacy of radiation therapy. Semin Hematol 2000; 37: 4 - 8.
9. Subramaniam S, Shyama S Shyamala Devi CS. Erythrocyte antioxidant enzyme activity in CMF treated breast cancer patients. Cancer Biochem Biophys 1994; 14: 177 - 82.
10. Smigel K. Vitamin E reduces prostate cancer rates in Finnish trials: US considers follow - up. J Natl Cancer Inst 1998; 90: 416 - 17.
11. Ziegler RG, Mayne ST, Swanson CA. Nutrition and lung cancer. Cancer Causes Control 1996; 7: 157 - 66.
12. Glossmann H, Neville DM. Glycoprotein of cell surface comparative study of three different cell surfaces of the rat. J Biol Chem 1971; 246: 6339 - 46.
13. Winzler RJ. Methods of Biochemical Analysis, In: Determination of serum glycoproteins, Inter Science Publishers, New York. 1955; Vol II: pp.279 - 311.
14. Wagner L. A more sensitive assay discriminating galactosamine and glucosamine in mixture. Anal Biochem 1979; 94: 394 - 96.
15. Dische Z, hettles LB. Spectrophotometric micro method for their determination.J Biol Chem 1948 ; 175: 595 - 604.
16. Narayana S. Sialic acid as a tumor marker. Ann Clin Lab Sci 1994; 24: 376 - 84.
17. Rajpure KB, Patel PS, Chawda JG, Shah RM. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous and oral cancer. J Oral Pathol Med 2005; 34: 263 -7.
18. Shashikanth MC, Rao RB. Study of serum fucose and serum sialic acid levels in oral squamous cell carcinoma. Ind J Dent Res 1994; 5: 119 - 24.
19. Sen U, Guha S, Chowdhury JR. Serum fucosyl transferase activity and serum fucose levels as diagnostic tools in malignancy. Acta Med Okayama 1983; 37: 457 - 62.
20. MacBeth RAL, Bekasi JG. Plasma glycoproteins in various disease states including carcinoma. Cancer Res 1962; 22: 1170 - 76.
21. Silver HK, Karin KA, Archibald EL, Salinas FA. Serum sialic acid and sialyltransferase as monitors of tumor burden in malignant melanoma patients. Cancer Res 1979; 39: 5036 - 42.
22. Lipton A, Harvey HA, Delong S. Glycoproteins and human cancer. Circulating levels in cancer serum. Cancer 1979; 43: 1766 - 71.
23. Kiricuta O, Bojan O, Comes R, Cristian R. Significance of serum fucose, sialic acid, hepatoglobin and phopholipid levels in the evaluation and treatment of breast cancer. Arch Geschvulstforsch. 1979; 49: 106 - 12.
24. Tanaka K, Tokumar US, Kojo S. Changes in the level of sialic acid in plasma, brain and liver of inherently scorbutic rats during vitamin C and E deficiencies. Biosci Biotech Biochem 1998; 62: 1592 - 93.
25. Soo CCY, Haqqani AS, Hidiroglou N, Swanson JE, Parker RS, Birrboim HC. Dose dependent effects of dietary (alpha) - and (gamma) - tocopherols on genetic instability in mouse mutatect tumors. J Natl Cancer Inst 2004; 96 :796 - 800.
26. Ebrahim AS, Gopalakrishnan R, Murugesan A, Sakthisekaran D. In vivo effect of vitamin E on serum and tissue glycoprotein levels in perchloroethylene induced cytotoxicity. Mol Cell Biochem 1995; 144: 13 - 8.
27. Byers T, Guerrero N. Epidemiologic evidence for vitamin C and vitamin E in cancer prevention. Am J Clin Nutri 1995; 62: 66 - 71.